COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics
Open Access
- 28 January 2021
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (4) , 998-1005
Abstract
Background: With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care. Objective: To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19. Design: A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days. Participants: We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey. Main Measures: The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience. Key Results: A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care. Conclusions: Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.Keywords
Funding Information
- California Department of Health and Health Care Services (18-95529)
This publication has 21 references indexed in Scilit:
- Policy Pathways to Address Provider Workforce Barriers to Buprenorphine TreatmentAmerican Journal of Preventive Medicine, 2018
- Why aren't physicians prescribing more buprenorphine?Journal of Substance Abuse Treatment, 2017
- Opioid agonist treatment for pharmaceutical opioid dependent peopleCochrane Database of Systematic Reviews, 2016
- From Triple to Quadruple Aim: Care of the Patient Requires Care of the ProviderThe Annals of Family Medicine, 2014
- Medication-Assisted Therapies — Tackling the Opioid-Overdose EpidemicNew England Journal of Medicine, 2014
- The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their RepairAnnual Review of Clinical Psychology, 2014
- Barriers to Primary Care Physicians Prescribing BuprenorphineThe Annals of Family Medicine, 2014
- Causes, Consequences, and Prevention of Burnout Among Substance Abuse Treatment Counselors: A Rural Versus Urban ComparisonJournal of Psychoactive Drugs, 2013
- Advancing a Conceptual Model of Evidence-Based Practice Implementation in Public Service SectorsAdministration and Policy in Mental Health and Mental Health Services Research, 2010
- Drug Dependence, a Chronic Medical IllnessJAMA, 2000